Arginine and Asymmetric Dimethylarginine in Pregnant Women with Major Depression
Overview
Affiliations
Objective: Depression has been associated with vascular dysfunction, which may be of particular relevance in pregnancy. Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA), and L-arginine play a critical role in vascular function. The objective of this study was to investigate differences in ADMA, SDMA, and L-arginine among pregnant women with major depression compared with pregnant women without depression.
Methods: A case-control study was conducted in 21 depressed pregnant women and 42 matched controls. Maternal plasma ADMA, SDMA, and L-arginine were quantified, as well as C-reactive protein and urine excretion of ADMA, SDMA, L-arginine, and Arginase I.
Results: Plasma L-arginine and ADMA levels were significantly lower in the first trimester in women with depression (mean [standard deviation = 37.0 [9.2] and 0.298 [0.06] μM, respectively) compared with matched controls (42.1 [11.4] and 0.336 [0.08] μM, p = .004 and p = .002, respectively) and across pregnancies (p < .001 both). Depressed pregnant women had higher levels of plasma C-reactive protein (7.5 [3.7] versus 5.1 [4.0] μg/ml, p = .027), but no differences in urine excretion of ADMA, SDMA, or L-arginine, or plasma levels of Arginase I (p > .10).
Conclusions: Pregnant women with depression show lower plasma levels of L-arginine and ADMA. These differences are not explained by urinary excretion or Arginase I levels. The mechanism responsible for the observed differences in depressed pregnant women requires further research.
Mechanisms of Homoarginine: Looking Beyond Clinical Outcomes.
Zubkowski A, Sferruzzi-Perri A, Wishart D Acta Physiol (Oxf). 2025; 241(2):e14273.
PMID: 39817883 PMC: 11737358. DOI: 10.1111/apha.14273.
Pre-pregnancy stress induces maternal vascular dysfunction during pregnancy and postpartum.
ODonnell M, Stumpp L, Gallaher M, Powers R Reprod Sci. 2023; 30(11):3197-3211.
PMID: 37219786 PMC: 10204668. DOI: 10.1007/s43032-023-01248-2.
Metabolomic markers of antepartum depression and suicidal ideation.
Mitro S, Larrabure-Torrealva G, Sanchez S, Molsberry S, Williams M, Clish C J Affect Disord. 2019; 262:422-428.
PMID: 31744743 PMC: 6917910. DOI: 10.1016/j.jad.2019.11.061.
Blood plasma metabolic profiling of pregnant women with antenatal depressive symptoms.
Henriksson H, Malavaki C, Brann E, Drainas V, Lager S, Iliadis S Transl Psychiatry. 2019; 9(1):204.
PMID: 31444321 PMC: 6707960. DOI: 10.1038/s41398-019-0546-y.
Damiati S J Med Biochem. 2018; 37(4):441-447.
PMID: 30584403 PMC: 6298471. DOI: 10.1515/jomb-2017-0069.